Etesian Wealth Advisors Inc. Has $652,000 Holdings in The Procter & Gamble Company (NYSE:PG)

Etesian Wealth Advisors Inc. decreased its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 16.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,763 shares of the company’s stock after selling 757 shares during the quarter. Etesian Wealth Advisors Inc.’s holdings in Procter & Gamble were worth $652,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of PG. Itau Unibanco Holding S.A. acquired a new position in Procter & Gamble during the 2nd quarter worth about $28,000. Fairway Wealth LLC bought a new position in shares of Procter & Gamble during the second quarter worth about $29,000. Ruedi Wealth Management Inc. lifted its stake in shares of Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the period. POM Investment Strategies LLC acquired a new position in shares of Procter & Gamble in the second quarter worth approximately $34,000. Finally, Quest Partners LLC acquired a new position in shares of Procter & Gamble in the second quarter worth approximately $36,000. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Up 0.0 %

NYSE PG opened at $171.28 on Friday. The company has a market cap of $404.24 billion, a price-to-earnings ratio of 27.99, a P/E/G ratio of 3.74 and a beta of 0.41. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The business has a 50 day moving average price of $171.77 and a 200-day moving average price of $167.16. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company’s quarterly revenue was down .6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.83 earnings per share. As a group, equities analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.35%. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.69%.

Insider Buying and Selling

In related news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 383,194 shares of company stock worth $65,140,718. 0.17% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on PG. Stifel Nicolaus lifted their price objective on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research note on Monday, July 22nd. TD Cowen began coverage on Procter & Gamble in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective on the stock. Dbs Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Evercore ISI lifted their price objective on Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. Finally, DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a research note on Thursday, August 29th. Nine analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $176.21.

View Our Latest Research Report on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.